Vividion Therapeutics

Vividion Therapeutics Overview

  • Founded
  • 2014
Founded
  • Status
  • Private
  • Employees
  • 70
Employees
  • Latest Deal Type
  • Series B
  • Latest Deal Amount
  • $82M
Latest Deal Amount
  • Investors
  • 12

Vividion Therapeutics General Information

Description

Developer of a novel drug discovery platform designed to offer transformative treatments to patients with serious illnesses. The company's platform applies chemical proteomics to expand the druggable proteome and addresses difficult targets providing transformative treatments, enabling healthcare professionals to eliminate artifacts and create proteome-wide drug interaction maps, for simultaneous target engagement and global selectivity profiling.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 5820 Nancy Ridge Drive
  • San Diego, CA 92121
  • United States
+1 (858) 000-0000

Vividion Therapeutics Timeline

2017201820192020
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Vividion Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series B) 30-Apr-2019 $82M 00000 00000 Completed Startup
4. Corporate 05-Mar-2018 00000 000.00 Completed Startup
3. Early Stage VC (Series A3) 24-Oct-2017 00.00 000.00 00000 Completed Startup
2. Early Stage VC (Series A2) 02-Feb-2017 $50M $53.5M 0000 Completed Startup
1. Early Stage VC (Series A) 11-Apr-2016 $3.5M $3.5M 000 Completed Startup

Vividion Therapeutics Cap Table

To view Vividion Therapeutics‘s complete cap table, request access »
Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.00
Series A-3 0,000,000 00.000000 00 00.0 00.0 00 00.0 0.000
Series A-2 67,333,334 $0.001000 6% $0.6 $0.6 1x $0.6 32.53%
Series A 18,118,465 $0.001000 6% $0.25 $0.25 1x $0.25 8.75%

Vividion Therapeutics Competitors (33)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing
Amount
Cedilla Therapeutics Venture Capital-Backed Cambridge, MA 00 000.00 00000000000 000.00
000 000000000000 Venture Capital-Backed Boston, MA 00 000.00 0000000000 0 000.00
000000 0000 Formerly VC-backed Jerusalem, Israel 00 00000 00000000 00000
000000000 00000000 Venture Capital-Backed Rockville, MD 000.00 0000000000 0 000.00
000000 00000000000 Corporation Cambridge, MA 000 00000 000000 - 000 00000

Vividion Therapeutics Executive Team (15)

Name Title Board Seat Contact Info
Diego Miralles MD Chief Executive Officer & Board Member
Fred Aslan MD President & Chief Business Officer
Trisha Millican Chief Financial Officer
Robert Abraham Chief Scientific Officer
Nick Veomett Executive

1 Former Executive

Vividion Therapeutics Board Members (9)

To view Vividion Therapeutics‘s full board member team, request access »
Name Representing Role Since
Benjamin Cravatt Ph.D Self Scientific Co-Founder & Board Member 000 0000
Diego Miralles MD Vividion Therapeutics Chief Executive Officer & Board Member 000 0000
Jakob Loven Ph.D Nextech Invest Board Member 000 0000
John Clarke Self President & Board Member 000 0000
Kristina Burow ARCH Venture Partners Board Member 000 0000

Vividion Therapeutics Investors (12)

To view Vividion Therapeutics‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Alexandria Venture Investments Corporate Venture Capital Minority 000 0000 000000 0
Altitude Life Science Ventures Venture Capital Minority 000 0000 000000 0
BVF Partners Hedge Fund Minority 000 0000 000000 0
Casdin Capital Hedge Fund Minority 000 0000 000000 0
Mirae Asset Capital Other Minority 000 0000 000000 0

Ready to get started?

Request a free trial